A Trusted Partner for Biosimilar Characterisation

We Understand Biosimilars

The functional testing requirements of biosimilar antibodies continually expands as new information surrounding the mechanisms of action of these complex molecules is reported and becomes the next regulatory requirement. At the same time, our understanding of antibody performance across different assay formats and the degree to which structural changes influence activity improves as we refine existing approaches and develop new methods.

Antibody Analytics is at the forefront of functional characterisation and have developed a range of proprietary methods based upon novel cell lines and adopted unique approaches to comparability studies that deliver significant technical advantages to our customers whilst reducing turnaround times and the costs associated with traditional CRO models. We can provide expert advice on the most appropriate functional characterisation strategies across all stages of biosimilar development, tailored to the specific performance of your molecule.

Contact us to discuss functional testing strategies for your molecules

Biosimilar Molecules

We offer testing services for the biosimilar antibodies listed below with assays for a number of additional molecules in development.

Pertuzumab
Adalimumab
Bevacizumab
Secukinumab
Nivolumab
Denosumab
Etanercept
Golimumab
Infliximab
Rituximab
Tocilizumab
Trastuzumab
Ustekinumab

Assay Formats

Our biosimilar testing capabilities cover a wide range of functional assay classes:

Potency and Binding Assays
ADCC Assessment Strategies
CDC Assessment Strategies
ADCP Assessment Strategies
Investigatory MOA Assays

Want to find out more? Click here to contact us